Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference
leading, global full-service clinical research organization, today announced
J.P. Morgan Healthcare Conference in
The public is invited to listen to a live webcast of Kendle’s presentation
at http://www.kendle.com (click on the link provided in the Investor Events
and Presentations section). An archived version can be accessed approximately
three hours following Kendle’s presentation and will be available until
and Presentations section.
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical
research organization providing the full range of early- to late-stage
clinical development services for the world’s biopharmaceutical industry. Our
focus is on innovative solutions that reduce cycle times for our customers and
accelerate the delivery of life-enhancing drugs to market for the benefit of
patients worldwide. As one of the fastest-growing global providers of Phase
I-IV services, we offer experience spanning 90 countries, along with
industry-leading patient access and retention capabilities and broad
therapeutic expertise, to meet our customers’ clinical development challenges.
Kendle was recognized by FORTUNE magazine as one of the 100
fastest-growing companies in
been recognized as “Top CRO to Work With” in the CenterWatch 2007 survey of
U.S. investigative sites and was named among the top three
CROs to work with in its 2008 survey of European investigative sites.
Additional information and investor kits are available upon request from
Kendle, 441 Vine Street, Suite 1200,
Company’s Web site at http://www.kendle.com .
SOURCE Kendle International Inc.